Q1 2024 Holdings
Filed 2024-05-14 | 105 holdings | $845.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(IVV) | CORE S&P500 ETF | 464287200 | $129.9M | 247,110 | 15.4% |
| Vanguard Index FDS(VOO) | S&P 500 ETF SHS | 922908363 | $129.4M | 269,110 | 15.3% |
| Vanguard Tax-Managed FDS(VEA) | VAN FTSE DEV MKT | 921943858 | $73.5M | 1,464,600 | 8.7% |
| Ishares TR(IEFA) | CORE MSCI EAFE | 46432F842 | $54.6M | 735,780 | 6.5% |
| Vanguard Intl Equity Index F(VWO) | FTSE EMR MKT ETF | 922042858 | $38.1M | 912,960 | 4.5% |
| Ishares Inc(IEMG) | CORE MSCI EMKT | 46434G103 | $33.3M | 646,200 | 3.9% |
| Ishares TR(ITOT) | CORE S&P TTL STK | 464287150 | $24.4M | 211,260 | 2.9% |
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $24.3M | 93,660 | 2.9% |
| Anheuser Busch Inbev SA(BUD) | SPONSORED ADR | 03524A108 | $16.4M | 270,100 | 1.9% |
| Sharkninja Inc(SN) | COM SHS | G8068L108 | $14.8M | 237,500 | 1.8% |
| Aercap Holdings NV(AER) | SHS | N00985106 | $12.2M | 140,000 | 1.4% |
| Kaspi KZ JSC(KSPI) | SPONSORED ADS | 48581R205 | $11.2M | 87,000 | 1.3% |
| American Healthcare REIT Inc(AHR) | COM SHS | 398182303 | $9.9M | 670,000 | 1.2% |
| Oddity Tech LTD(ODD) | SHS CL A | M7518J104 | $8.9M | 205,000 | 1.1% |
| General Electric Co(GE) | COM NEW | 369604301 | $8.4M | 48,000 | 1.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $8.3M | 620,000 | 1.0% |
| BBB Foods Inc(TBBB) | CL A COM | G0896C103 | $7.7M | 323,369 | 0.9% |
| Gates Indl Corp PLC | ORD SHS | G39108108 | $7.6M | 430,000 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.8M | 100,000 | 0.8% |
| Nasdaq Inc(NDAQ) | COM | 631103108 | $6.6M | 105,000 | 0.8% |
| Viper Energy Inc(VNOMUSD) | CL A | 927959106 | $6.3M | 165,000 | 0.8% |
| Super Micro Computer Inc(SMCIUSD) | COM | 86800U104 | $6.1M | 6,000 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.8M | 115,000 | 0.7% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $5.8M | 890,000 | 0.7% |
| Corebridge Finl Inc(CRBG) | COM | 21871X109 | $5.7M | 200,000 | 0.7% |
| REV Group Inc(1RG) | COM | 749527107 | $5.7M | 258,938 | 0.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $5.5M | 125,000 | 0.6% |
| Kinetik Holdings Inc(KNTK) | COM NEW CL A | 02215L209 | $5.0M | 125,000 | 0.6% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $5.0M | 55,364 | 0.6% |
| Radnet Inc(RDNT) | COM | 750491102 | $4.9M | 100,000 | 0.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $4.8M | 170,000 | 0.6% |
| Ichor Holdings(ICHR) | SHS | G4740B105 | $4.7M | 122,960 | 0.6% |
| Symbotic Inc(SYM) | CLASS A COM | 87151X101 | $4.7M | 105,161 | 0.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $4.3M | 1,000,000 | 0.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.1M | 3,459,854 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.1M | 94,714 | 0.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $4.0M | 170,000 | 0.5% |
| Matador RES Co(MTDR) | COM | 576485205 | $4.0M | 60,000 | 0.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $3.8M | 380,000 | 0.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $3.7M | 350,000 | 0.4% |
| TD Synnex Corporation(SNX) | COM | 87162W100 | $3.7M | 32,500 | 0.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.7M | 87,500 | 0.4% |
| Napco SEC Technologies Inc(NSSC) | COM | 630402105 | $3.6M | 90,000 | 0.4% |
| Perella Weinberg Partners(PWP) | CLASS A COM | 71367G102 | $3.6M | 252,066 | 0.4% |
| Auna S A(AUNA) | CLASS A | L0415A103 | $3.5M | 325,000 | 0.4% |
| Essential Pptys Rlty TR Inc(EPRT) | COM | 29670E107 | $3.3M | 125,000 | 0.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $3.3M | 132,500 | 0.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.2M | 100,000 | 0.4% |
| Atmus Filtration Technologie(ATMU) | COM | 04956D107 | $3.2M | 100,000 | 0.4% |
| Chewy Inc(CHWY) | CL A | 16679L109 | $3.2M | 200,000 | 0.4% |